MEMBER'S LOGINX
| Invalid Username / Password | ||||||||
| Invalid Captcha | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
India's Third Giant Leap
This Could be One of the Biggest Opportunities for Investors
- Home
- Stock Quote
- Sector Info (List of mnc pharma Stocks)
- MNC Pharma Stocks
MNC Pharma
Stocks 
Here are the latest stock price details of India's top MNC Pharma stocks. For more detailed updates, read our MNC Pharma sector report and check the latest MNC Pharma sector results. Also check out Equitymaster's powerful stock screener to find the top pharma companies in India.
| SCRIP | BSE PRICE (Rs) | NSE PRICE (Rs) | CHART | MORE INFO |
|---|---|---|---|---|
| ABBOTT INDIA | 27,165.00 -0.11% | 27,120.00 -0.38% |
|
More Info
|
| GSK PHARMA | 2,376.50 -2.45% | 2,365.00 -2.99% |
|
More Info
|
| NIFTY 50 | Not Listed | 23,346.75 -0.73% |
|
More Info
|
| NOVARTIS | 1,025.00 0.21% | Not Listed |
|
More Info
|
| PFIZER | 5,122.75 -1.19% | 5,127.90 -0.98% |
|
More Info
|
| PROCTER & GAMBLE HEALTH | 5,080.00 -1.07% | 5,097.00 -0.90% |
|
More Info
|
| S&P BSE HEALTHCARE | 42,447.07 0.11% | Not Listed |
|
More Info
|
| S&P BSE SENSEX | 77,155.79 -0.54% | Not Listed |
|
More Info
|
| SANOFI INDIA | 6,050.00 -1.61% | 6,078.95 -1.13% |
|
More Info
|
BSE prices: November 21, 2024 03:34:00 PM NSE prices: November 21, 2024 3:29:59 PM
MNC Pharma Stocks Update
The NIFTY PHARMA Index was at 21,695.7 (down 0.3%). The index is down 7.1% over the last 30 days. And over the last 1 year, it has gained 37.3%.
Within the MNC Pharma sector, the top gainer was NOVARTIS (up 0.2%). On the other hand, GSK PHARMA (down 2.5%) and SANOFI INDIA (down 1.6%) were among the top losers.
Meanwhile, the benchmark NIFTY 50 was at 23,346.8 (down 0.7%).
Before you go, here are the upcoming corporate actions for MNC Pharma stocks.
Upcoming Dividends
| COMPANY | PRICE (Rs) | CHANGE (%) | DIVIDEND (%) | RECORD DATE | EX-DIVIDEND DATE |
|---|---|---|---|---|---|
| PROCTER & GAMBLE HEALTH | 5,080.00 | -1.07 | 600.0 | 29-Nov-24 | 28-Nov-24 |
List of All Upcoming Dividends
FAQs
Which are the top MNC Pharma companies in India?
Based on marketcap, these are the top MNC Pharma companies in India:
You can see the full list of pharmaceuticals stocks here.
And for a fundamental analysis of the above companies, check out Equitymaster’s Indian stock screener which has a separate screen for top pharma companies in India .
What are the top gainers and top losers within the MNC Pharma sector today?
Within the MNC Pharma sector, the top gainers was NOVARTIS (up 0.2%). On the other hand, GSK PHARMA (down 2.5%) and SANOFI INDIA (down 1.6%) were among the top losers.
For more, please check out our pharma sector report.
How should you value MNC Pharma companies?
Investing in stocks requires careful analysis of financial data to find out a company's true worth. However, an easier way to find out about a company's performance is to look at its financial ratios.
Two commonly used financial ratios used in the valuation of stocks are -
Price to Earnings Ratio (P/E) - It compares the company's stock price with its earnings per share. The higher the P/E ratio, the more expensive the stock.
Price to Book Value Ratio (P/BV) - It compares a firm's market capitalization to its book value. A high P/BV indicates markets believe the company's assets to be undervalued and vice versa.
To know more about the healthcare sector's past and ongoing performance, have a look at the performance of the BSE Healthcare Index.
Which are some important indices one should track?
It depends on one's specific interests and investment goals.
Some popular sectoral indices to track in addition to the broader market indices are BSE IT index, BSE realty index, BSE manufacturing index and BSE auto index.
It's important to research and understand the industries and companies included in each sectoral index to make informed investment decisions.
Today's Market
![Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%]()
Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Multibagger Penny Stocks
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Best Small-cap Stocks to Buy
- Best Bluechip Stocks to Buy
- Guide to Penny Stocks
- How to Invest in the Share Market
- Warren Buffett - The Value Investor
- Pick the Best Multibagger Stocks
TRENDING TOPICS
Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407
Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com
LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.